INFLAMMATORY BOWEL DISEASE: OUTPATIENT TREATMENT PROFILE

Rachael Miranda Dos Santos1,2, Ana Teresa Pugas Carvalho1, Kelly Dos Santos Silva1

  • 1Ambulatório de Doenças Inflamatórias Intestinais, Disciplina de Gastroenterologia, Policlínica Piquet Carneiro, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Insights

Inflammatory bowel disease (IBD) is increasingly prevalent. This study describes IBD patient profiles in Brazil, finding a high incidence in white females, with Crohn's disease and the stenotic phenotype being most common.

Area of Science:

  • Gastroenterology
  • Epidemiology
  • Internal Medicine

Background:

  • Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, presents a growing global health challenge.
  • Rising incidence and prevalence rates, coupled with disease severity and recurrence, underscore the need for robust epidemiological data.
  • A deficit in Brazilian epidemiological data for IBD contributes to patient vulnerability and increased morbidity.

Purpose of the Study:

  • To characterize the demographic and clinical profiles of patients diagnosed with inflammatory bowel disease.
  • To provide a comprehensive overview of IBD patient cohorts within a Brazilian outpatient setting.

Main Methods:

  • A descriptive, exploratory, and retrospective documentary study was conducted.
  • Data were collected from 556 patients at an IBD outpatient service in Rio de Janeiro, Brazil, between May and July 2016.
  • Quantitative analysis was employed following ethical approval.

Main Results:

  • A notable prevalence of IBD was observed in white female patients.
  • Crohn's disease was diagnosed more frequently than ulcerative colitis.
  • The ileocolon represented the most affected site in Crohn's disease patients, with a prevalent stenotic phenotype.

Conclusions:

  • The high prevalence of the stenotic phenotype in Crohn's disease warrants further investigation within the Brazilian context.
  • The epidemiological profile of the studied population aligns with existing national and international literature.
  • Understanding these profiles is crucial for improving IBD patient care and management in Brazil.
Abstract

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
875
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
990
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
588
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
618
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
579
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
789